Related Experiment Videos
The role of platelet-activating factor in experimental immune complex pathology
International Journal of Tissue Reactions
|January 1, 1985
Summary
Platelet-activating factor (PAF) promotes immune complex deposition in the heart, lungs, and kidneys by increasing vascular permeability. However, PAF does not affect immune deposits at sites of blood flow turbulence.
Area of Science:
- Immunology
- Pathology
- Pharmacology
Background:
- Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
- Understanding the role of PAF in immune complex (IC) localization is crucial for inflammatory disease research.
Purpose of the Study:
- To investigate the effect of synthetic PAF on the tissue distribution of immune complexes in a rabbit model.
- To determine if PAF influences IC deposition in specific organs or at sites of blood flow turbulence.
Main Methods:
- Rabbits were infused with synthetic PAF before or after intravenous injection of bovine serum albumin (BSA) and anti-BSA antibodies.
- Control groups received BSA and anti-BSA antibodies without PAF, or with lyso-PAF/saline-BSA.
- Tissue localization of BSA, IgG, and complement component C3 was assessed.
Main Results:
- PAF infusion induced vascular permeability changes in the heart, lung, and kidney.
- Significant deposits of BSA, IgG, and C3 were observed in the heart, lung, and kidney of PAF-infused rabbits.
- Immune deposits were infrequent in the liver of PAF-infused rabbits but consistently found in cardiac valves, aorta, and renal artery bifurcation, similar to controls.
Conclusions:
- PAF enhances the localization of immune complexes in the vasculature of the heart, lungs, and kidneys.
- PAF does not appear to influence the formation of immune deposits at anatomical sites characterized by blood flow turbulence.